APO Research
Talk to an analyst

APO RESEARCH · REPORT

Long-acting Reversible Contraceptives (LARCs)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Long-acting Reversible Contraceptives (LARCs) Market Outlook and Growth Opportunities 2026

4 July 2026208 pages

Choose your research edition.

Industry ResearchLong-acting Reversible Contraceptives (LARCs) Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-acting Reversible Contraceptives (LARCs) Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Long-acting Reversible Contraceptives (LARCs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-acting Reversible Contraceptives (LARCs) Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-acting Reversible Contraceptives (LARCs) Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Long-acting Reversible Contraceptives (LARCs) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Long-acting Reversible Contraceptives (LARCs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Long-acting Reversible Contraceptives (LARCs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Long-acting Reversible Contraceptives (LARCs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Long-acting Reversible Contraceptives (LARCs) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Long-acting Reversible Contraceptives (LARCs) market include AbbVie Allergan, ASPIVIX, Cooper Companies, Durbin, H & J Medical, HRA Pharma, Laboratoire 7 MED, Laboratoire CCD and OCON, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Long-acting Reversible Contraceptives (LARCs) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Long-acting Reversible Contraceptives (LARCs) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Long-acting Reversible Contraceptives (LARCs) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Long-acting Reversible Contraceptives (LARCs) market size, projected growth trends, production technologies, key applications, and end-use industries.

Long-acting Reversible Contraceptives (LARCs) Segment by Company

AbbVie Allergan

ASPIVIX

Cooper Companies

Durbin

H & J Medical

HRA Pharma

Laboratoire 7 MED

Laboratoire CCD

OCON

Pregna

Prosan

Shanghai Dahua Pharmaceuticals

Williams Medical Supplies

Yantai JiShengYaoXie

Bayer

Merck

Long-acting Reversible Contraceptives (LARCs) Segment by Type

Copper Intrauterine Devices

Hormonal Intrauterine Devices

Contraceptive Implants

Others

Long-acting Reversible Contraceptives (LARCs) Segment by Application

Age 20-24

Age 25-34

Age 35-44

Others

Long-acting Reversible Contraceptives (LARCs) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Long-acting Reversible Contraceptives (LARCs) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Long-acting Reversible Contraceptives (LARCs) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Long-acting Reversible Contraceptives (LARCs) significant trends, drivers, influence factors in global and regions.

6. To analyze Long-acting Reversible Contraceptives (LARCs) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-acting Reversible Contraceptives (LARCs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-acting Reversible Contraceptives (LARCs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-acting Reversible Contraceptives (LARCs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Long-acting Reversible Contraceptives (LARCs) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Long-acting Reversible Contraceptives (LARCs) industry.

Chapter 3: Detailed analysis of Long-acting Reversible Contraceptives (LARCs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Long-acting Reversible Contraceptives (LARCs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Long-acting Reversible Contraceptives (LARCs) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Long-acting Reversible Contraceptives (LARCs) Industry Trends Table 2. Long-acting Reversible Contraceptives (LARCs) Industry Drivers Table 3. Long-acting Reversible Contraceptives (LARCs) Industry Opportunities and Challenges Table 4. Long-acting Reversible Contraceptives (LARCs) Industry Restraints Table 5. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Company (2021-2026) Table 7. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Company (k units) & (2021-2026) Table 8. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume Share by Company (2021-2026) Table 9. Global Long-acting Reversible Contraceptives (LARCs) Average Price (USD/unit) of Company (2021-2026) Table 10. Global Long-acting Reversible Contraceptives (LARCs) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Long-acting Reversible Contraceptives (LARCs) Key Company Manufacturing Base & Headquarters Table 12. Global Long-acting Reversible Contraceptives (LARCs) Company, Product Type & Application Table 13. Global Long-acting Reversible Contraceptives (LARCs) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Long-acting Reversible Contraceptives (LARCs) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Copper Intrauterine Devices Table 18. Significant Companies of Hormonal Intrauterine Devices Table 19. Significant Companies of Contraceptive Implants Table 20. Significant Companies of Others Table 21. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Type (2021-2026) & (k units) Table 23. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Type (2027-2032) & (k units) Table 24. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume Share by Type (2021-2026) Table 25. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume Share by Type (2027-2032) Table 26. Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type (2021-2026) Table 30. Global Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Age 20-24 Table 32. Significant Companies of Age 25-34 Table 33. Significant Companies of Age 35-44 Table 34. Significant Companies of Others Table 35. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Application (2021-2026) & (k units) Table 37. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Application (2027-2032) & (k units) Table 38. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume Share by Application (2021-2026) Table 39. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume Share by Application (2027-2032) Table 40. Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application (2021-2026) Table 44. Global Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application (2027-2032) Table 45. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2021-2026) & (k units) Table 47. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2021-2026) Table 48. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2027-2032) & (k units) Table 49. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2027-2032) Table 50. Global Long-acting Reversible Contraceptives (LARCs) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Region (2021-2026) Table 53. Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Region (2027-2032) Table 55. Global Long-acting Reversible Contraceptives (LARCs) Market Average Price (USD/unit) by Region (2021-2026) Table 56. Global Long-acting Reversible Contraceptives (LARCs) Market Average Price (USD/unit) by Region (2027-2032) Table 57. Global Long-acting Reversible Contraceptives (LARCs) Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026) & (k units) Table 60. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2021-2026) Table 61. Global Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032) & (k units) Table 62. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2027-2032) Table 63. Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Long-acting Reversible Contraceptives (LARCs) Sales Value Market Share by Country (2021-2026) Table 65. Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Long-acting Reversible Contraceptives (LARCs) Sales Value Market Share by Country (2027-2032) Table 67. AbbVie Allergan Company Information Table 68. AbbVie Allergan Business Overview Table 69. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 71. AbbVie Allergan Recent Development Table 72. ASPIVIX Company Information Table 73. ASPIVIX Business Overview Table 74. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 76. ASPIVIX Recent Development Table 77. Cooper Companies Company Information Table 78. Cooper Companies Business Overview Table 79. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 81. Cooper Companies Recent Development Table 82. Durbin Company Information Table 83. Durbin Business Overview Table 84. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 86. Durbin Recent Development Table 87. H & J Medical Company Information Table 88. H & J Medical Business Overview Table 89. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 91. H & J Medical Recent Development Table 92. HRA Pharma Company Information Table 93. HRA Pharma Business Overview Table 94. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 96. HRA Pharma Recent Development Table 97. Laboratoire 7 MED Company Information Table 98. Laboratoire 7 MED Business Overview Table 99. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 101. Laboratoire 7 MED Recent Development Table 102. Laboratoire CCD Company Information Table 103. Laboratoire CCD Business Overview Table 104. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 106. Laboratoire CCD Recent Development Table 107. OCON Company Information Table 108. OCON Business Overview Table 109. OCON Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 111. OCON Recent Development Table 112. Pregna Company Information Table 113. Pregna Business Overview Table 114. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 116. Pregna Recent Development Table 117. Prosan Company Information Table 118. Prosan Business Overview Table 119. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 121. Prosan Recent Development Table 122. Shanghai Dahua Pharmaceuticals Company Information Table 123. Shanghai Dahua Pharmaceuticals Business Overview Table 124. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 126. Shanghai Dahua Pharmaceuticals Recent Development Table 127. Williams Medical Supplies Company Information Table 128. Williams Medical Supplies Business Overview Table 129. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 131. Williams Medical Supplies Recent Development Table 132. Yantai JiShengYaoXie Company Information Table 133. Yantai JiShengYaoXie Business Overview Table 134. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 136. Yantai JiShengYaoXie Recent Development Table 137. Bayer Company Information Table 138. Bayer Business Overview Table 139. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 141. Bayer Recent Development Table 142. Merck Company Information Table 143. Merck Business Overview Table 144. Merck Long-acting Reversible Contraceptives (LARCs) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolio Table 146. Merck Recent Development Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Long-acting Reversible Contraceptives (LARCs) Distributors List Table 150. Long-acting Reversible Contraceptives (LARCs) Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Long-acting Reversible Contraceptives (LARCs) Product Image Figure 2. Global Long-acting Reversible Contraceptives (LARCs) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-acting Reversible Contraceptives (LARCs) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Long-acting Reversible Contraceptives (LARCs) Sales (2021-2032) & (k units) Figure 5. Global Long-acting Reversible Contraceptives (LARCs) Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Long-acting Reversible Contraceptives (LARCs) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Copper Intrauterine Devices Image Figure 10. Hormonal Intrauterine Devices Image Figure 11. Contraceptive Implants Image Figure 12. Others Image Figure 13. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume Share by Type (2021-2032) Figure 16. Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Long-acting Reversible Contraceptives (LARCs) Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type (2021-2032) Figure 19. Age 20-24 Image Figure 20. Age 25-34 Image Figure 21. Age 35-44 Image Figure 22. Others Image Figure 23. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Long-acting Reversible Contraceptives (LARCs) Sales Volume Share by Application (2021-2032) Figure 26. Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Long-acting Reversible Contraceptives (LARCs) Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application (2021-2032) Figure 29. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Long-acting Reversible Contraceptives (LARCs) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Long-acting Reversible Contraceptives (LARCs) Sales Value (2021-2032) & (US$ Million) Figure 34. North America Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Long-acting Reversible Contraceptives (LARCs) Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Long-acting Reversible Contraceptives (LARCs) Sales Value (2021-2032) & (US$ Million) Figure 40. South America Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Long-acting Reversible Contraceptives (LARCs) Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Long-acting Reversible Contraceptives (LARCs) Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Copper Intrauterine Devices
  • Hormonal Intrauterine Devices
  • Contraceptive Implants
  • Others
Applications
  • Age 20-24
  • Age 25-34
  • Age 35-44
  • Others
Companies covered
  • AbbVie Allergan
  • ASPIVIX
  • Cooper Companies
  • Durbin
  • H & J Medical
  • HRA Pharma
  • Laboratoire 7 MED
  • Laboratoire CCD
  • OCON
  • Pregna
  • Prosan
  • Shanghai Dahua Pharmaceuticals
  • Williams Medical Supplies
  • Yantai JiShengYaoXie
  • Bayer
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Value (2021-2032)
  4. 1.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Volume (2021-2032)
  5. 1.2.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Long-acting Reversible Contraceptives (LARCs) Market Dynamics
  1. 2.1 Long-acting Reversible Contraceptives (LARCs) Industry Trends
  2. 2.2 Long-acting Reversible Contraceptives (LARCs) Industry Drivers
  3. 2.3 Long-acting Reversible Contraceptives (LARCs) Industry Opportunities and Challenges
  4. 2.4 Long-acting Reversible Contraceptives (LARCs) Industry Restraints
3 Long-acting Reversible Contraceptives (LARCs) Market by Company
  1. 3.1 Global Long-acting Reversible Contraceptives (LARCs) Company Revenue Ranking in 2025
  2. 3.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Company (2021-2026)
  3. 3.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Company (2021-2026)
  4. 3.4 Global Long-acting Reversible Contraceptives (LARCs) Average Price by Company (2021-2026)
  5. 3.5 Global Long-acting Reversible Contraceptives (LARCs) Company Ranking (2024-2026)
  6. 3.6 Global Long-acting Reversible Contraceptives (LARCs) Company Manufacturing Base and Headquarters
  7. 3.7 Global Long-acting Reversible Contraceptives (LARCs) Company Product Type and Application
  8. 3.8 Global Long-acting Reversible Contraceptives (LARCs) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Long-acting Reversible Contraceptives (LARCs) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Long-acting Reversible Contraceptives (LARCs) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Long-acting Reversible Contraceptives (LARCs) Market by Type
  1. 4.1 Long-acting Reversible Contraceptives (LARCs) Type Introduction
  2. 4.1.1 Copper Intrauterine Devices
  3. 4.1.2 Hormonal Intrauterine Devices
  4. 4.1.3 Contraceptive Implants
  5. 4.1.4 Others
  6. 4.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Type
  7. 4.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Type
  11. 4.3.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Type (2021-2032)
  13. 4.3.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type (2021-2032)
5 Long-acting Reversible Contraceptives (LARCs) Market by Application
  1. 5.1 Long-acting Reversible Contraceptives (LARCs) Application Introduction
  2. 5.1.1 Age 20-24
  3. 5.1.2 Age 25-34
  4. 5.1.3 Age 35-44
  5. 5.1.4 Others
  6. 5.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Application
  7. 5.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Application
  11. 5.3.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application (2021-2032)
6 Long-acting Reversible Contraceptives (LARCs) Regional Sales and Value Analysis
  1. 6.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2021-2032)
  3. 6.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region: 2021-2026
  4. 6.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2027-2032)
  5. 6.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Region (2027-2032)
  9. 6.5 Global Long-acting Reversible Contraceptives (LARCs) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Long-acting Reversible Contraceptives (LARCs) Sales Value (2021-2032)
  12. 6.6.2 North America Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales Value (2021-2032)
  15. 6.7.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Long-acting Reversible Contraceptives (LARCs) Sales Value (2021-2032)
  21. 6.9.2 South America Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Country, 2025 VS 2032
7 Long-acting Reversible Contraceptives (LARCs) Country-level Sales and Value Analysis
  1. 7.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2032)
  4. 7.3.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Country (2021-2026)
  5. 7.3.2 Global Long-acting Reversible Contraceptives (LARCs) Sales by Country (2027-2032)
  6. 7.4 Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Long-acting Reversible Contraceptives (LARCs) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Long-acting Reversible Contraceptives (LARCs) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AbbVie Allergan
  2. 8.1.1 AbbVie Allergan Company Information
  3. 8.1.2 AbbVie Allergan Business Overview
  4. 8.1.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  6. 8.1.5 AbbVie Allergan Recent Developments
  7. 8.2 ASPIVIX
  8. 8.2.1 ASPIVIX Company Information
  9. 8.2.2 ASPIVIX Business Overview
  10. 8.2.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  12. 8.2.5 ASPIVIX Recent Developments
  13. 8.3 Cooper Companies
  14. 8.3.1 Cooper Companies Company Information
  15. 8.3.2 Cooper Companies Business Overview
  16. 8.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  18. 8.3.5 Cooper Companies Recent Developments
  19. 8.4 Durbin
  20. 8.4.1 Durbin Company Information
  21. 8.4.2 Durbin Business Overview
  22. 8.4.3 Durbin Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  24. 8.4.5 Durbin Recent Developments
  25. 8.5 H & J Medical
  26. 8.5.1 H & J Medical Company Information
  27. 8.5.2 H & J Medical Business Overview
  28. 8.5.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  30. 8.5.5 H & J Medical Recent Developments
  31. 8.6 HRA Pharma
  32. 8.6.1 HRA Pharma Company Information
  33. 8.6.2 HRA Pharma Business Overview
  34. 8.6.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  36. 8.6.5 HRA Pharma Recent Developments
  37. 8.7 Laboratoire 7 MED
  38. 8.7.1 Laboratoire 7 MED Company Information
  39. 8.7.2 Laboratoire 7 MED Business Overview
  40. 8.7.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  42. 8.7.5 Laboratoire 7 MED Recent Developments
  43. 8.8 Laboratoire CCD
  44. 8.8.1 Laboratoire CCD Company Information
  45. 8.8.2 Laboratoire CCD Business Overview
  46. 8.8.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  48. 8.8.5 Laboratoire CCD Recent Developments
  49. 8.9 OCON
  50. 8.9.1 OCON Company Information
  51. 8.9.2 OCON Business Overview
  52. 8.9.3 OCON Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  54. 8.9.5 OCON Recent Developments
  55. 8.10 Pregna
  56. 8.10.1 Pregna Company Information
  57. 8.10.2 Pregna Business Overview
  58. 8.10.3 Pregna Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  60. 8.10.5 Pregna Recent Developments
  61. 8.11 Prosan
  62. 8.11.1 Prosan Company Information
  63. 8.11.2 Prosan Business Overview
  64. 8.11.3 Prosan Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  66. 8.11.5 Prosan Recent Developments
  67. 8.12 Shanghai Dahua Pharmaceuticals
  68. 8.12.1 Shanghai Dahua Pharmaceuticals Company Information
  69. 8.12.2 Shanghai Dahua Pharmaceuticals Business Overview
  70. 8.12.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  72. 8.12.5 Shanghai Dahua Pharmaceuticals Recent Developments
  73. 8.13 Williams Medical Supplies
  74. 8.13.1 Williams Medical Supplies Company Information
  75. 8.13.2 Williams Medical Supplies Business Overview
  76. 8.13.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  78. 8.13.5 Williams Medical Supplies Recent Developments
  79. 8.14 Yantai JiShengYaoXie
  80. 8.14.1 Yantai JiShengYaoXie Company Information
  81. 8.14.2 Yantai JiShengYaoXie Business Overview
  82. 8.14.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  84. 8.14.5 Yantai JiShengYaoXie Recent Developments
  85. 8.15 Bayer
  86. 8.15.1 Bayer Company Information
  87. 8.15.2 Bayer Business Overview
  88. 8.15.3 Bayer Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  90. 8.15.5 Bayer Recent Developments
  91. 8.16 Merck
  92. 8.16.1 Merck Company Information
  93. 8.16.2 Merck Business Overview
  94. 8.16.3 Merck Long-acting Reversible Contraceptives (LARCs) Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolio
  96. 8.16.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Long-acting Reversible Contraceptives (LARCs) Value Chain Analysis
  2. 9.1.1 Long-acting Reversible Contraceptives (LARCs) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Long-acting Reversible Contraceptives (LARCs) Sales Mode & Process
  6. 9.2 Long-acting Reversible Contraceptives (LARCs) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Long-acting Reversible Contraceptives (LARCs) Distributors
  9. 9.2.3 Long-acting Reversible Contraceptives (LARCs) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst